NCA - Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439R) - Decision Memo

Moyer VA; U.S. Preventive Services Task Force (USPSTF). Screening for lung cancer: U.S. PreventiveServices Task Force recommendation statement. Ann Intern Med. 2014 Mar 4;160(5):330-8. doi: 10.7326/M13-2771. PMID: 24378917.Naidich DP, Marshall CH, Gribbin C, et al. Low-dose CT of the lungs: preliminary observations. Radiology. 1990 Jun;175(3):729-31. doi: 10.1148/radiology.175.3.2343122. PMID: 2343122.National Institutes of Health, National Cancer Institute. Computed Tomography (CT) Scans andCancer. What is computed tomography? Published in 2019. https://www.cancer.gov/about-cancer/diagnosis-staging/ct-scans-fact-sheet#what-is-computed-tomography. Accessed October 1, 2021.National Lung Screening Trial Research Team (NLST). Lung Cancer Incidence and Mortality withExtended Follow-up in the National Lung Screening Trial. J Thorac Oncol. 2019 Oct;14(10):1732-1742.doi: 10.1016/j.jtho.2019.05.044. PMID: 31260833.National Lung Screening Trial Research (NLST) Team, Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. PMID: 21714641.Nawa T, Fukui K, Nakayama T, et al. A population-based cohort study to evaluate the effectiveness of lung cancer screening using low-dose CT in Hitachi city, Japan. Jpn J Clin Oncol. 2019 Feb 1;49(2):130-136. doi: 10.1093/jjco/hyy185. PMID: 30541133.NCCN (National Comprehensive Cancer Network). NCCN Clinical Practice Guidelines in Oncology(NCCN Guidelines): Lung Cancer Screening, Version 1.2021  December 17, 2020.https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf. Accessed 6/17/2021.NCI (National Cancer Institute). Surveillance, Epidemiology, and End Results Program: Cancer Stat Facts: lung and bronchus cancer. https://seer.cancer.gov/statfacts/html/lungb.html. Accessed October 1, 2021.Paci E, Puliti D, Carozzi FM, et al. Prognostic selection and long-term survival analysis to assessoverdiagnosis risk in lung cancer screening randomized trials. J Med Screen. 2021 Mar;28(1):39-47. doi: 10.1177/0969141320923030. PMID: 32437229.Paci E, Puliti D, Lopes Pegna A, et al. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax. 2017 Sep;72(9):825-831. doi: 10.1136/thoraxjnl-2016-209825. PMID: 28377492.Pastorino U, Silva M, Sestini S, et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019 Jul 1;30(7):1162-1169. doi: 10.1093/annonc/mdz117. PMID: 30937431.Pastorino U, Sverzellati N, Sestini S, et al. Ten-year results of the Multicentric ItalianLung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening. Eur J Cancer. 2019 Sep;118:142-148. doi: 10.1016/j.ejca.2019.06.009. PMID: 31336289.Patz EF Jr, Greco E, Gatsonis C, et al. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol. 2016 May;17(5):590-9. doi: 10.1016/S1470-2045(15)00621-X. PMID: 27009070.Patz EF Jr, Pinsky P, Gatsonis C, et al.; NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014 Feb 1;174(2):269-74. doi: 10.1001/jamainternmed.2013.12738. PMID: 24322569.Pham D, Bhandari S, Pinkston C, et al. Lung Cancer Screening Registry Reveals Low-dose CT Screening Remains Heavily Underutilized. Clin Lung Cancer. 2020 May;21(3):e206-e211. doi: 10.1016/j.cllc.2019.09.002. PMID: 32001154.Rampinelli C, De Marco P, Origgi D, et al. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ. 2017 Feb 8;356:j347. doi: 10.1136/bmj.j347. PMID: 28179230.Reese TJ, Schlechter CR, Potter LN, et al. Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations. JAMA Netw Open.2021 Jan 4;4(1):e2033769. doi: 10.1001/jamanetworkopen.2020.33769.PMID: 33433600.Reitsma M, Kendrick P, Anderson J, et al. Reexamining Rates of Decline in Lung CancerRisk after Smoking Cessation. A Meta-analysis. Ann Am Thorac Soc. 2020 Sep;17(9):1126-1132. doi: 10.1513/AnnalsATS.201909-659OC. PMID: 32603182Rivera MP, Katki HA, Tanner NT, et al. Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement. Am J Respir Crit Care Med. 2020 Oct 1;202(7):e95-e112. doi: 10.1164/rccm.202008-3053ST. PMID: 33000953.Rulli KS, Matthews E. Using Low-Dose Computed Tomography for Early Detection of Lung Cancer. Radiol Technol. 2020 Sep;92(1):23-31. PMID: 32879014.Sadate A, Occean BV, Beregi JP, et al. Systematic review and meta-analysis on the impact of lung cancer screening by low-dose computed tomography. Eur J Cancer. 2020 Jul;134:107-114.doi: 10.1016/j.ejca.2020.04.035. PMID: 32502939 DOI: 10.1016/j.ejca.2020.04.035.Samet JM. Health benefits of smoking cessation. Clin Chest Med. 1991;12(4):669-679.Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12. PMID: 33433946.Sox HC. Implementing Lung Cancer Screening Under Medicare: The Last Chance to Get It Right? JAMA. 2014 Sep24;312(12):1206-1207. doi: 10.1001/jama.2014.12921.Tanner NT, Kanodra NM, Gebregziabher M, et al. The Association between Smoking Abstinenceand Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 1;193(5):534-41. doi: 10.1164/rccm.201507-1420OC. PMID: 26502000.Tindle HA, Stevenson Duncan M, Greevy RA, et al. Lifetime Smoking History and Risk of LungCancer: Results From the Framingham Heart Study. J Natl Cancer Inst. 2018 Nov 1;110(11):1201-1207. doi: 10.1093/jnci/djy041. PMID: 29788259Travis WD, Brambilla E, Nicholson AG, et al; WHO Panel. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630. PMID: 26291008.US Preventive Services Task Force (USPSTF). Lung cancer screening: recommendation statement. Ann Intern Med. 2004 May 4;140(9):738-9. doi: 10.7326/0003-4819-140-9-200405040-00014. PMID: 15126258.US Preventive Services Task Force (USPSTF), Krist AH, Davidson KW, Mangione CM, et al. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 Mar 9;325(10):962-970. doi: 10.1001/jama.2021.1117. PMID: 33687470.van Ballegooijen M, Rutter CM, Knudsen AB, et al. Clarifying differences in natural historybetween models of screening: the case of colorectal cancer. Med Decis Making. 2011 Jul-Aug;31(4):540-9. doi: 10.1177/0272989X11408915. PMID: 21673187.Wang X, Liu H, Shen Y, et al. Low-dose computed tomography (LDCT) versus other cancer screenings inearly diagnosis of lung cancer: A meta-analysis. Medicine (Baltimore). 2018 Jul;97(27):e11233.doi: 10.1097/MD.0000000000011233. PMID: 2997938.Wang Y, Midthun DE, Wampfler JA, et al. Trends in the proportion of patients with lung cancer meeting screening criteria. JAMA. 2015 Feb 24;313(8):853-5. doi: 10.1001/jama.2015.413. PMID:25710663Wender R, Fontham ET, Barrera E Jr, et al.  American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013 Mar-Apr;63(2):107-17. doi: 10.3322/caac.21172. PMID: 23315954.White LJ, Kaur A, Lapel RT, et al. Lung Cancer Screening at a Military Treatment Facility: A Retrospective Review. Mil Med. 2020 Jun 8;185(5-6):e864-e869. doi: 10.1093/milmed/usz386. PMID: 31925432.Whittaker Brown SA, Padilla M, et al. Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial. Chest. 2019 Dec;156(6):1195-1203. doi: 10.1016/j.chest.2019.06.041. PMID: 31404527.Wiener RS, Gould MK, Arenberg DA, et al. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med. 2015 Oct 1;192(7):881-91. doi: 10.1164/rccm.201508-1671ST. PMID: 26426785.Wille MM, Dirksen A, Ashraf H, et al. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling. Am J Respir Crit Care Med. 2016 Mar 1;193(5):542-51. doi: 10.1164/rccm.201505-1040OC. PMID: 26485620.Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. World Health Organization, 1968. Available at: http://whqlibdoc.who.int/php/WHO_PHP_34.pdf.